首页> 外文期刊>Tissue engineering, Part B. Reviews >A meta-analysis of histomorphometric results and graft healing time of various biomaterials compared to autologous bone used as sinus floor augmentation material in humans.
【24h】

A meta-analysis of histomorphometric results and graft healing time of various biomaterials compared to autologous bone used as sinus floor augmentation material in humans.

机译:与用于人体窦底增强材料的自体骨相比,对各种生物材料的组织形态计量学结果和移植物愈合时间进行荟萃分析。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: To date, no studies have been published in which histomorphometric data from a large group of patients comparing various biomaterials for sinus floor augmentation procedures were evaluated. MATERIALS AND METHODS: A meta-analysis of the English literature from January 1993 till April 2009 was carried out. Out of 147 titles, according to our criteria, 64 articles were selected for analysis describing the use of autologous bone and their alternatives, such as allogenic, xenogenic, and alloplastic materials. RESULTS: On the basis of autologous bone grafting, a reference value for total bone volume (TBV) of 63% was found. Particulation of the bone graft resulted in a general reduction of -18% in TBV. Delayed implant placement reduced the TBV with -7%. Overall TBV was 8% or 6% higher if a biopsy was, respectively, taken before 4.5 months or after 9.0 months after initial sinus augmentation surgery. Allogenic, xenogenic, alloplastic, or combinations of graft materials all resulted in a significant lower amount of TBV compared to autologous bone grafting ranging from -7% to -26%. Inventorying the effect of "biopsy time" for autologous bone, the TBV was significantly higher before 4.5 and after 9.0 months of healing time compared to period in between. Surprisingly, no significant differences in TBV with respect to "biopsy time" for bone substitutes were found. CONCLUSIONS: On the basis of the aspect of TBV autologous bone still has to be considered to be the gold standard in sinus augmentation surgery. However, the consequence of the TBV for implant survival is still unraveled yet.
机译:背景:迄今为止,尚未发表任何研究,其中未评估来自大量患者的组织形态计量学数据,这些数据比较了各种生物材料用于鼻窦底增大手术的情况。材料与方法:对1993年1月至2009年4月英语文献进行荟萃分析。根据我们的标准,在147个标题中,选择了64篇文章进行分析,描述了自体骨及其替代品的使用,例如同种异体,异种和异体材料。结果:在自体骨移植的基础上,发现总骨体积(TBV)的参考值为63%。植骨的颗粒化导致TBV总体降低-18%。延迟植入植入物可将TBV降低-7%。如果在初次鼻窦增强手术后4.5个月之前或9.0个月后进行活检,则总TBV分别高8%或6%。与自体骨移植相比,同种异体,异种,同种异体或移植材料的组合均导致TBV的数量明显降低,范围为-7%至-26%。盘点“活检时间”对自体骨的影响,与之间的时间相比,TBV在愈合时间4.5和9.0个月后显着更高。出人意料的是,在骨替代物的“活检时间”方面,没有发现TBV有显着差异。结论:基于TBV方面,自体骨仍必须被视为鼻窦增高手术的金标准。但是,TBV对植入物存活的影响尚未阐明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号